The above property of Pin1 inhibitors are desirable for treating aggressive solid tumors such as HCC, because HCC caused by various etiologies has a high intertumor and intratumor heterogeneity, with multiple interactive and/or redundant cancer-driving pathways being activated simultaneously in the same patient34, 35, 36, 37. Here, PIN1 is linked to hepatocellular carcinoma.